Can physicians and schools mitigate social inequalities in human papillomavirus vaccine awareness, uptake and vaccination intention among adolescents? A cross-sectional study, France, 2021 to 2022.


Journal

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452

Informations de publication

Date de publication:
Nov 2023
Historique:
medline: 20 11 2023
pubmed: 17 11 2023
entrez: 16 11 2023
Statut: ppublish

Résumé

BackgroundIn France, human papillomavirus (HPV) vaccination coverage varies across socioeconomic levels.AimWe aimed at assessing HPV vaccine awareness, uptake and vaccination intention among adolescents in France.MethodsIn a cluster-randomised study, 13-15-year-old students in 61 French middle schools completed a web-based questionnaire. We used multivariable logistic regression to evaluate determinants of HPV vaccine awareness, self-reported uptake and vaccination intention among unvaccinated students and interaction terms to explore effects of visits to family physician and remembering school lessons on vaccination. The French deprivation index of school municipalities served as proxy for socioeconomic levels.ResultsAmong 6,992 participants, awareness was significantly associated with parental education (odds ratio (OR) = 0.82; 95% confidence interval (CI): 0.71-0.95), language spoken at home (OR = 0.59; 95% CI: 0.52-0.66) and deprivation level (OR = 0.57; 95% CI: 0.44-0.71), regardless of physician visit or school lessons. Vaccine uptake was associated with parental education without a recent physician visit (OR = 0.31; 95% CI: 0.16-0.59, vs OR = 0.64; 95% CI: 0.52-0.78 with a visit, interaction p = 0.045). Vaccination intention among unvaccinated was associated with deprivation level (moderate-low vs low) among students not remembering school lessons on vaccination (OR = 0.17; 95% CI: 0.05-0.62, vs OR = 0.93; 95% CI: 0.51-1.67 remembering school lessons, interaction p = 0.022). Parental education was associated with vaccination intention among students reporting a physician visit (OR = 0.41; 95% CI: 0.26-0.64 vs OR = 1.05; 95% CI: 0.50-2.20 without a visit, interaction p = 0.034).ConclusionOur results suggest that healthcare and school could promote vaccination and mitigate social inequalities in HPV vaccination coverage.

Identifiants

pubmed: 37971661
doi: 10.2807/1560-7917.ES.2023.28.46.2300166
pmc: PMC10655205
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Randomized Controlled Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Vaccine. 2016 Feb 3;34(6):762-8
pubmed: 26752063
J Prim Care Community Health. 2017 Oct;8(4):349-362
pubmed: 29161946
J Community Health. 2017 Apr;42(2):400-412
pubmed: 27734247
Vaccine. 2015 Sep 22;33(39):5188-95
pubmed: 26254978
Expert Rev Vaccines. 2018 Apr;17(4):311-321
pubmed: 29569498
BMC Public Health. 2009 Jan 22;9:33
pubmed: 19161613
Hum Vaccin Immunother. 2019;15(7-8):1615-1627
pubmed: 30633623
Sante Publique. 2020 Jun 18;Vol. 32(1):29-41
pubmed: 32706224
Public Health Rev. 2020 May 14;41:10
pubmed: 32435520
PLoS One. 2020 Oct 22;15(10):e0234693
pubmed: 33091021
Vaccine. 2021 Jun 29;39(29):3916-3925
pubmed: 34088507
N Engl J Med. 2023 May 11;388(19):1790-1798
pubmed: 37163625
Hum Vaccin Immunother. 2021 Nov 2;17(11):4470-4486
pubmed: 34473589
Hum Vaccin Immunother. 2018 Jul 3;14(7):1566-1572
pubmed: 29303677
Hum Vaccin Immunother. 2016 Jun 2;12(6):1454-68
pubmed: 26838681
BMJ Open. 2022 Mar 24;12(3):e057943
pubmed: 35332045
Asian Pac J Cancer Prev. 2021 Feb 01;22(2):349-357
pubmed: 33639647
Vaccine X. 2019 Aug 05;3:100037
pubmed: 31463471
Soc Sci Med. 2013 Apr;82:115-25
pubmed: 23337830
BMC Public Health. 2013 Jul 09;13:640
pubmed: 23837819
Vaccines (Basel). 2021 Jun 05;9(6):
pubmed: 34198885
Hum Vaccin Immunother. 2019;15(7-8):1752-1759
pubmed: 30735440
Hum Vaccin Immunother. 2019;15(7-8):1465-1475
pubmed: 30779682
Vaccine. 2020 Feb 5;38(6):1315-1331
pubmed: 31836255

Auteurs

Hadrien Moffroid (H)

Institut Pasteur, Université Paris Cité, Emerging Disease Epidemiology Unit, 75015 Paris, France.
University of Melbourne, Melbourne, Australia.

Damien Oudin Doglioni (DO)

Institut Pasteur, Université Paris Cité, Emerging Disease Epidemiology Unit, 75015 Paris, France.

Sandra Chyderiotis (S)

Institut Pasteur, Université Paris Cité, Emerging Disease Epidemiology Unit, 75015 Paris, France.

Jonathan Sicsic (J)

Université Paris Cité, LIRAES, 75006, Paris, France.

Anne-Sophie Barret (AS)

Santé Publique France, St Maurice, France.

Jocelyn Raude (J)

Université Rennes, EHESP, CNRS, Inserm, Arènes - UMR 6051, RSMS (Recherche sur les Services et Management en Santé) - U1309 - 35000 Rennes, France.

Sebastien Bruel (S)

Department of General Practice, Faculté de Médecine Jacques Lisfranc, Université Jean Monnet, Université de Lyon, Saint-Etienne, France.
Health, Systemic, Process UR 4129 Research Unit, University Claude Bernard, University of Lyon, Lyon, France.

Aurelie Gauchet (A)

Université Savoie Mont Blanc, Université Grenoble Alpes LIP/PC2S, Grenoble, France.

Morgane Michel (M)

Assistance Publique-Hôpitaux de Paris, Hôpital Robert Debré, Unité d'épidémiologie clinique, Paris, France.
Université Paris Cité, ECEVE, UMR1123, Inserm, Paris, France.

Amandine Gagneux-Brunon (A)

CHU de Saint-Etienne - Service d'infectiologie.
Centre International de Recherche en Infectiologie, Team GIMAP, Université de Lyon, Université Jean Monnet, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530.

Nathalie Thilly (N)

Université de Lorraine, APEMAC, Nancy, France.
Université de Lorraine, CHRU-Nancy, Département Méthodologie, Promotion, Investigation, Nancy, France.

Judith E Mueller (JE)

Institut Pasteur, Université Paris Cité, Emerging Disease Epidemiology Unit, 75015 Paris, France.
Université Rennes, EHESP, CNRS, Inserm, Arènes - UMR 6051, RSMS (Recherche sur les Services et Management en Santé) - U1309 - 35000 Rennes, France.
Members of the PrevHPV Consortium are listed under acknowledgements.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH